Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters.

Chace DH, Lim T, Hansen CR, De Jesus VR, Hannon WH.

Clin Chim Acta. 2009 Sep;407(1-2):6-9. doi: 10.1016/j.cca.2009.06.017. Epub 2009 Jun 21.

PMID:
19545553
2.

Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

Turgeon C, Magera MJ, Allard P, Tortorelli S, Gavrilov D, Oglesbee D, Raymond K, Rinaldo P, Matern D.

Clin Chem. 2008 Apr;54(4):657-64. doi: 10.1373/clinchem.2007.101949. Epub 2008 Feb 15.

3.

Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process.

Dhillon KS, Bhandal AS, Aznar CP, Lorey FW, Neogi P.

Clin Chim Acta. 2011 May 12;412(11-12):873-9. doi: 10.1016/j.cca.2010.12.028. Epub 2011 Jan 7.

PMID:
21216241
4.

Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.

De Jesús VR, Chace DH, Lim TH, Mei JV, Hannon WH.

Clin Chim Acta. 2010 May 2;411(9-10):684-9. doi: 10.1016/j.cca.2010.01.034. Epub 2010 Feb 1.

PMID:
20122909
5.

Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.

Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, Rinaldo P, Matern D.

Mol Genet Metab. 2006 May;88(1):16-21. Epub 2006 Jan 31.

PMID:
16448836
6.

Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine.

Metz TF, Mechtler TP, Merk M, Gottschalk A, Lukačin R, Herkner KR, Kasper DC.

Clin Chim Acta. 2012 Aug 16;413(15-16):1259-64. doi: 10.1016/j.cca.2012.04.007. Epub 2012 Apr 12.

PMID:
22521492
7.

Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.

Fingerhut R, Ensenauer R, Röschinger W, Arnecke R, Olgemöller B, Roscher AA.

Anal Chem. 2009 May 1;81(9):3571-5. doi: 10.1021/ac8022235.

PMID:
19323528
8.

Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.

Al-Dirbashi OY, Rashed MS, Jacob M, Al-Ahaideb LY, Al-Amoudi M, Rahbeeni Z, Al-Sayed MM, Al-Hassnan Z, Al-Owain M, Al-Zeidan H.

Biomed Chromatogr. 2008 Nov;22(11):1181-5. doi: 10.1002/bmc.1049.

PMID:
18651606
9.
10.

Preliminary proficiency testing results for succinylacetone in dried blood spots for newborn screening for tyrosinemia type I.

Adam BW, Lim TH, Hall EM, Hannon WH.

Clin Chem. 2009 Dec;55(12):2207-13. doi: 10.1373/clinchem.2009.133819. Epub 2009 Oct 22.

11.

Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry.

Holub M, Tuschl K, Ratschmann R, Strnadová KA, Mühl A, Heinze G, Sperl W, Bodamer OA.

Clin Chim Acta. 2006 Nov;373(1-2):27-31. Epub 2006 Jun 22.

PMID:
16797519
12.

Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry.

Al-Dirbashi OY, Rashed MS, Brink HJ, Jakobs C, Filimban N, Al-Ahaidib LY, Jacob M, Al-Sayed MM, Al-Hassnan Z, Faqeih E.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):274-80. Epub 2005 Dec 27.

PMID:
16384749
13.

Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.

Sander J, Janzen N, Peter M, Sander S, Steuerwald U, Holtkamp U, Schwahn B, Mayatepek E, Trefz FK, Das AM.

Clin Chem. 2006 Mar;52(3):482-7. Epub 2006 Jan 26.

14.

Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific.

Fingerhut R, Röschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, Superti-Furga A, Troxler H, Liebl B, Olgemöller B, Roscher AA.

Clin Chem. 2001 Oct;47(10):1763-8.

15.

Precursor ion scan profiles of acylcarnitines by atmospheric pressure thermal desorption chemical ionization tandem mass spectrometry.

Paglia G, D'Apolito O, Corso G.

Rapid Commun Mass Spectrom. 2008 Dec;22(23):3809-15. doi: 10.1002/rcm.3799.

PMID:
18980266
16.
17.

Acylcarnitines: analysis in plasma and whole blood using tandem mass spectrometry.

Millington DS, Stevens RD.

Methods Mol Biol. 2011;708:55-72. doi: 10.1007/978-1-61737-985-7_3.

PMID:
21207283
18.

Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry.

Minkler PE, Stoll MS, Ingalls ST, Yang S, Kerner J, Hoppel CL.

Clin Chem. 2008 Sep;54(9):1451-62. doi: 10.1373/clinchem.2007.099226. Epub 2008 Aug 4.

19.

The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.

la Marca G, Malvagia S, Pasquini E, Innocenti M, Fernandez MR, Donati MA, Zammarchi E.

Rapid Commun Mass Spectrom. 2008;22(6):812-8. doi: 10.1002/rcm.3428.

PMID:
18278819
20.

Supplemental Content

Support Center